Hemisphere Energy Gelecekteki Büyüme
Future kriter kontrolleri 0/6
Hemisphere Energy's revenue and earnings are forecast to decline at 1% and 11.6% per annum respectively while EPS is expected to decline by 6.6% per annum.
Anahtar bilgiler
-11.6%
Kazanç büyüme oranı
-6.6%
EPS büyüme oranı
Oil and Gas kazanç büyümesi | 6.4% |
Gelir büyüme oranı | -1.0% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Low |
Son güncelleme | 26 Sep 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Hemisphere Energy (CVE:HME) Is Due To Pay A Dividend Of CA$0.025
Aug 23Hemisphere Energy (CVE:HME) Has Affirmed Its Dividend Of CA$0.025
Jan 30Hemisphere Energy (CVE:HME) Is Due To Pay A Dividend Of CA$0.025
Aug 28Here's Why We Think Hemisphere Energy (CVE:HME) Is Well Worth Watching
Mar 04We Think Hemisphere Energy (CVE:HME) Can Manage Its Debt With Ease
Jun 08We Think Hemisphere Energy (CVE:HME) Can Stay On Top Of Its Debt
Feb 03Hemisphere Energy (CVE:HME) Is Looking To Continue Growing Its Returns On Capital
Nov 24Hemisphere Energy (CVE:HME) Has A Somewhat Strained Balance Sheet
Aug 18Here's Why Shareholders Will Not Be Complaining About Hemisphere Energy Corporation's (CVE:HME) CEO Pay Packet
Jun 09These 4 Measures Indicate That Hemisphere Energy (CVE:HME) Is Using Debt Extensively
May 12Will The ROCE Trend At Hemisphere Energy (CVE:HME) Continue?
Mar 20Is Hemisphere Energy (CVE:HME) A Risky Investment?
Jan 26Is There More Growth In Store For Hemisphere Energy's (CVE:HME) Returns On Capital?
Dec 02Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | 87 | 26 | 6 | N/A | 1 |
12/31/2025 | 100 | 34 | 15 | 47 | 1 |
12/31/2024 | 101 | 36 | 12 | 46 | 2 |
6/30/2024 | 77 | 30 | 24 | 43 | N/A |
3/31/2024 | 69 | 25 | 17 | 38 | N/A |
12/31/2023 | 68 | 24 | 27 | 44 | N/A |
9/30/2023 | 65 | 23 | 19 | 40 | N/A |
6/30/2023 | 63 | 24 | 24 | 40 | N/A |
3/31/2023 | 70 | 23 | 28 | 46 | N/A |
12/31/2022 | 72 | 21 | 27 | 45 | N/A |
9/30/2022 | 74 | 24 | 23 | 41 | N/A |
6/30/2022 | 64 | 16 | 17 | 34 | N/A |
3/31/2022 | 46 | 9 | 11 | 23 | N/A |
12/31/2021 | 35 | 6 | 6 | 18 | N/A |
9/30/2021 | 24 | 0 | 9 | 16 | N/A |
6/30/2021 | 21 | 0 | 9 | 13 | N/A |
3/31/2021 | 19 | 0 | 7 | 9 | N/A |
12/31/2020 | 17 | 0 | 8 | 9 | N/A |
9/30/2020 | 21 | -3 | 9 | 11 | N/A |
6/30/2020 | 22 | -2 | 3 | 11 | N/A |
3/31/2020 | 26 | 4 | 2 | 13 | N/A |
12/31/2019 | 28 | 2 | 0 | 10 | N/A |
9/30/2019 | 22 | 5 | -4 | 7 | N/A |
6/30/2019 | 19 | 2 | -9 | 6 | N/A |
3/31/2019 | 18 | -3 | -10 | 3 | N/A |
12/31/2018 | 15 | -5 | -14 | 2 | N/A |
9/30/2018 | 15 | -8 | -17 | 2 | N/A |
6/30/2018 | 13 | -8 | -12 | 1 | N/A |
3/31/2018 | 10 | -6 | N/A | 1 | N/A |
12/31/2017 | 9 | -4 | N/A | 2 | N/A |
9/30/2017 | 8 | -1 | N/A | 2 | N/A |
6/30/2017 | 7 | -1 | N/A | 2 | N/A |
3/31/2017 | 7 | -2 | N/A | 1 | N/A |
12/31/2016 | 6 | -3 | N/A | 0 | N/A |
9/30/2016 | 5 | -4 | N/A | 0 | N/A |
6/30/2016 | 5 | -9 | N/A | 1 | N/A |
3/31/2016 | 7 | -9 | N/A | 2 | N/A |
12/31/2015 | 9 | -8 | N/A | 3 | N/A |
9/30/2015 | 11 | -10 | N/A | 5 | N/A |
6/30/2015 | 13 | -4 | N/A | 6 | N/A |
3/31/2015 | 13 | -3 | N/A | 7 | N/A |
12/31/2014 | 14 | -2 | N/A | 7 | N/A |
9/30/2014 | 12 | 0 | N/A | 6 | N/A |
6/30/2014 | 11 | 0 | N/A | 5 | N/A |
3/31/2014 | 10 | 0 | N/A | 3 | N/A |
12/31/2013 | 9 | -1 | N/A | 4 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: HME's earnings are forecast to decline over the next 3 years (-11.6% per year).
Kazançlar ve Piyasa: HME's earnings are forecast to decline over the next 3 years (-11.6% per year).
Yüksek Büyüme Kazançları: HME's earnings are forecast to decline over the next 3 years.
Gelir ve Pazar: HME's revenue is expected to decline over the next 3 years (-1% per year).
Yüksek Büyüme Geliri: HME's revenue is forecast to decline over the next 3 years (-1% per year).
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if HME's Return on Equity is forecast to be high in 3 years time